Previous Close | 0.2000 |
Open | 0.2100 |
Bid | 0.1500 |
Ask | 0.2700 |
Strike | 55.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.2000 - 0.2100 |
Contract Range | N/A |
Volume | |
Open Interest | 281 |
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
Multi-asset funds have been put forward as one way to manage the impact of a mooted capital gains tax hike on investment portfolios.